Pradžia › Dermatomiozitas › Merilendas
Dermatomiozitas klinikiniai tyrimai Merilendas
9 tyrimai dėl Dermatomiozitas ieško dalyvių vietose Merilendas.
Miestai Merilendas
Oficialus tyrimo tekstas (anglų kalba)
FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM)
- National Institutes of Health Clinical Center, Bethesda
Renkami dalyviai2 fazė
Amžius nuo 18 iki 60 · Visoms lytims · Atnaujinta 2026-10-02 · NCT07111065Environmental Risk Factors for the Anti-synthetase Syndrome
- National Institutes of Health Clinical Center, Bethesda
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius nuo 2 iki 100 · Visoms lytims · Atnaujinta 2026-09-28 · NCT01276470A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
- Research Site, Baltimore
Renkami dalyviai3 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-24 · NCT06455449Natural History of Inflammatory Muscle Diseases
- National Institutes of Health Clinical Center, Bethesda
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius nuo 2 iki 120 · Visoms lytims · Atnaujinta 2026-09-24 · NCT05738824Adult and Juvenile Myositis
- National Institutes of Health Clinical Center, Bethesda
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius nuo 2 iki 100 · Visoms lytims · Atnaujinta 2026-09-24 · NCT00017914Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-23 · NCT03816345RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- National Institutes of Health - Accepting Adult and Juvenile Patients, Bethesda
Renkami dalyviai2/3 fazė
Amžius nuo 6 iki 75 · Visoms lytims · Atnaujinta 2026-09-17 · NCT06154252A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Johns Hopkins Hospital, Baltimore
Renkami dalyviai1 fazė
Amžius nuo 18 iki 74 · Visoms lytims · Atnaujinta 2026-09-10 · NCT07085104Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
- Johns Hopkins University, Baltimore
Renkami dalyviai1 fazė
Amžius nuo 18 iki 85 · Visoms lytims · Atnaujinta 2026-07-22 · NCT06371417Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.